Home

Foresite Capital Fund II, L.P.

CIK 1594914 · last filed 2019-09-06

Foresite Capital Fund II, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider bought $15.0M of AERI on Sep 6, 2019. Across all open-market trades the lifetime net is +$2.7M, making them a net buyer over the disclosed history. The firm reports its address in San Francisco, CA. 29 SEC filings were submitted jointly with Foresite Capital Management II, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

6

Lifetime Open-Market Net

$2.75M

Filer Profile

Reported Address
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO, CA 94111
Phone
(415) 877-4887
State of Incorporation
DE
Related Filers
Foresite Capital Management II, LLC — 29 joint filings, latest 2020-05-14
James B. Tananbaum — 29 joint filings, latest 2020-05-14
Foresite Capital Fund III, L.P. — 20 joint filings, latest 2020-03-02
Foresite Capital Fund IV, L.P. — 9 joint filings, latest 2020-03-02
Foresite Capital Management IV, LLC — 9 joint filings, latest 2020-03-02
Foresite Capital Fund I, L.P. — 8 joint filings, latest 2020-05-14
FS Development Holdings II, LLC — same reported address
FS Development Holdings, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 2,350,477 $15.25 $35.84M $244.5K 5 2019-09-06
Aimmune Therapeutics, Inc. (AIMT) Delisted 10%+ Owner 355,020 — — $2.50M 1 2015-08-26

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-09-06 AERIE PHARMACEUTICALS INC (AERI) Delisted Buy (P) +811,300 $14.99M EDGAR
2019-09-04 AERIE PHARMACEUTICALS INC (AERI) Delisted Buy (P) +525,000 $11.02M EDGAR
2017-05-31 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −100,000 -$5.60M EDGAR
2016-10-11 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −250,000 -$10.08M EDGAR
2016-10-07 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −250,000 -$10.08M EDGAR
2015-08-26 Aimmune Therapeutics, Inc. (AIMT) Delisted Buy (P) +127,425 $2.50M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.